Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEURO COMP: Complexity Measures in Sensorimotor Behavior
NCT02610647Completed
- Sponsor
- CHU Nîmes
- Start
- Jun 2017
- Primary completion
- Aug 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine (5 arms), sponsored by CHU Nîmes. Primary endpoint: minmaxMF-DFA value at Day 0. Started Jun 2017; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on NCT02610647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610647.